Samsung Biologics
207940.KS
#372
Rank
โ‚น4.673 T
Marketcap
โ‚น65,664
Share price
6.95%
Change (1 day)
30.87%
Change (1 year)

Revenue for Samsung Biologics (207940.KS)

Revenue in 2024 (TTM): โ‚น277.91 Billion

According to Samsung Biologics 's latest financial reports the company's current revenue (TTM ) is โ‚น283.34 Billion. an increase over the revenue in the year 2023 that were of โ‚น233.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Samsung Biologics from 2016 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น283.51 B21.39%
2023 โ‚น233.54 B22.76%
2022 โ‚น190.24 B89.63%
2021 โ‚น100.32 B36.26%
2020 โ‚น73.62 B71.34%
2019 โ‚น42.97 B26.22%
2018 โ‚น34.04 B27.29%
2017 โ‚น26.74 B54.61%
2016 โ‚น17.29 B